Abbas Hajizadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abbas Hajizadeh has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Heydari
Department of Agronomy and Plant Breeding, Faculty of Agriculture, Zanjan University, Zanjan, Iran
1 shared publication - Ali Bidmeshkipour
Department of biology, Faculty of science, Razi University, Kermanshah, Iran
1 shared publication - Ashkan Haji Nour Mohammadi
Department of Biology, SR.C., Islamic Azad University, Tehran, Iran
1 shared publication Davoud Sadeghi
Department of Biological Sciences, Faculty of Science, Imam Hossein University, Tehran, Iran
1 shared publicationEmad Kordbacheh
Department of Biological Sciences, Faculty of Science, Imam Hossein University, Tehran, Iran
1 shared publicationHadis Kalantari
Department of Microbiology, La C., Islamic Azad University, Lahijan, Iran
1 shared publication
Latest Publications
- Open Access
- 1 October 2025
- Published by IWA Publishing in Journal of Water and Health
- Vol. 23 (10) , 1224-1239
Investigating the presence of virulence determinants and vancomycin-resistant genes in enterococci isolated from the Anzali Lagoon and recreational waters in Guilan Province, Iran
This study characterizes vancomycin-resistant Enterococci (VRE) in Iran's Anzali Lagoon recreational waters through analysis of 268 samples collected seasonally (2019). Culture and PCR methods identified Enterococcus in 57.5% (154/268) of samples, with 40.3% (62/154) showing vancomycin resistance. Resistance gene profiling revealed vanA and vanH predominance (56.5% each, 35/62), demonstrating complete co-occurrence, while vanB was rare (3.2%, 2/62) and vanC absent. Virulence factors displayed divergent prevalence: esp (62.9%, 39/62) exceeded clinical isolate rates, whereas hyl (3.2%, 2/62) was uncommon. Biofilm assays showed VRE isolates formed significantly denser biofilms than susceptible strains (2.3-fold higher OD570, p < 0.001), with esp-positive isolates exhibiting the strongest biofilm production. These findings demonstrate that recreational waters harbor VRE populations with: (1) elevated esp prevalence suggesting environmental selection pressures, and (2) enhanced biofilm capacity promoting persistence. The 100% vanA-vanH co-occurrence and 62.9% esp frequency surpass WHO risk thresholds for recreational waters, indicating need for revised monitoring protocols. This study provides the first evidence of aquatic-specific VRE genotypes in the region and their potential public health impacts through resistance gene dissemination and waterborne exposure risks.
- 1 October 2025
- Published by IWA Publishing in Journal of Water and Health
- Vol. 23 (10) , 1224-1239
Open AccessInvestigating the presence of virulence determinants and vancomycin-resistant genes in enterococci isolated from the Anzali Lagoon and recreational waters in Guilan Province, Iran
This study characterizes vancomycin-resistant Enterococci (VRE) in Iran's Anzali Lagoon recreational waters through analysis of 268 samples collected seasonally (2019). Culture and PCR methods identified Enterococcus in 57.5% (154/268) of samples, with 40.3% (62/154) showing vancomycin resistance. Resistance gene profiling revealed vanA and vanH predominance (56.5% each, 35/62), demonstrating complete co-occurrence, while vanB was rare (3.2%, 2/62) and vanC absent. Virulence factors displayed divergent prevalence: esp (62.9%, 39/62) exceeded clinical isolate rates, whereas hyl (3.2%, 2/62) was uncommon. Biofilm assays showed VRE isolates formed significantly denser biofilms than susceptible strains (2.3-fold higher OD570, p < 0.001), with esp-positive isolates exhibiting the strongest biofilm production. These findings demonstrate that recreational waters harbor VRE populations with: (1) elevated esp prevalence suggesting environmental selection pressures, and (2) enhanced biofilm capacity promoting persistence. The 100% vanA-vanH co-occurrence and 62.9% esp frequency surpass WHO risk thresholds for recreational waters, indicating need for revised monitoring protocols. This study provides the first evidence of aquatic-specific VRE genotypes in the region and their potential public health impacts through resistance gene dissemination and waterborne exposure risks.
- Open Access
- 19 September 2025
- Published by Taylor & Francis in Virulence
- Vol. 16 (1) , 2563018
Enterobactin: A key player in bacterial iron acquisition and virulence and its implications for vaccine development and antimicrobial strategies
Enterobactin, a high-affinity siderophore produced by Escherichia coli and other enteric pathogens, plays a critical role in bacterial iron acquisition and virulence. By sequestering iron from host environments, enterobactin enables bacterial survival and proliferation, even under iron-limited conditions typical of host tissues. This review explores the biosynthesis and regulation of enterobactin, highlighting its contribution to bacterial pathogenesis and immune evasion. We discuss the potential of targeting enterobactin for the development of live-attenuated vaccines, emphasizing the attenuation of virulence through genetic knockout of enterobactin biosynthesis genes (e.g. entB). Additionally, we examine enterobactin as a promising target for novel antimicrobial strategies, including small-molecule inhibitors and siderophore-based "Trojan horse" antibiotics. Beyond medical applications, we also explore the biotechnological and environmental potential of enterobactin, such as its use in bioremediation and drug delivery systems. Finally, we identify key gaps in current research and propose future directions for harnessing enterobactin to combat bacterial infections and address global health challenges. This review underscores the multifaceted role of enterobactin in bacterial biology and its potential as a cornerstone for innovative therapeutic and biotechnological applications.
- 19 September 2025
- Published by Taylor & Francis in Virulence
- Vol. 16 (1) , 2563018
Open AccessEnterobactin: A key player in bacterial iron acquisition and virulence and its implications for vaccine development and antimicrobial strategies
Enterobactin, a high-affinity siderophore produced by Escherichia coli and other enteric pathogens, plays a critical role in bacterial iron acquisition and virulence. By sequestering iron from host environments, enterobactin enables bacterial survival and proliferation, even under iron-limited conditions typical of host tissues. This review explores the biosynthesis and regulation of enterobactin, highlighting its contribution to bacterial pathogenesis and immune evasion. We discuss the potential of targeting enterobactin for the development of live-attenuated vaccines, emphasizing the attenuation of virulence through genetic knockout of enterobactin biosynthesis genes (e.g. entB). Additionally, we examine enterobactin as a promising target for novel antimicrobial strategies, including small-molecule inhibitors and siderophore-based "Trojan horse" antibiotics. Beyond medical applications, we also explore the biotechnological and environmental potential of enterobactin, such as its use in bioremediation and drug delivery systems. Finally, we identify key gaps in current research and propose future directions for harnessing enterobactin to combat bacterial infections and address global health challenges. This review underscores the multifaceted role of enterobactin in bacterial biology and its potential as a cornerstone for innovative therapeutic and biotechnological applications.
- 23 February 2022
- Published by Elsevier in Molecular Immunology
- Vol. 144, 96-105
In silico and in vivo approaches to recombinant multi-epitope immunogen of GroEL provides efficient cross protection against S. Typhimurium, S. flexneri, and S. dysenteriae
- 23 February 2022
- Published by Elsevier in Molecular Immunology
- Vol. 144, 96-105
In silico and in vivo approaches to recombinant multi-epitope immunogen of GroEL provides efficient cross protection against S. Typhimurium, S. flexneri, and S. dysenteriae
- 1 April 2020
- Published by Apex Publishing in Iranian Journal of Toxicology
- Vol. 14 (2) , 105-110
Antibacterial Activity of the Iranian Scorpion’s Crude Venom (Odontobuthus bidentatus) on Gram-positive and Gram-negative Bacteria
Background: The venoms of some scorpions are rich in bioactive components that may be used in the development and discovery of new antibacterial drugs. The venoms have many components, such as neurotoxins, salts, proteins and peptides with therapeutic properties, and can rapidly eliminate a broad range of bacteria. This study evaluated the anti-bacterial activity of Odontobuthus bidentatus’ crude venom against typical Gram-positive and negative bacteria, such as Staphylococcus aureus, Bacillus subtilis, and Escherichia coli. Methods: The antibacterial effects of the crude venom were evaluated using Minimal Inhibitory Concentration (MIC) and MTT assays and its IC50 value was determined, using GraphPad software. Results: The crude venom significantly inhibited the growth of both Gram-positive and negative bacteria. Also the MTT results showed that the crude venom significantly reduced the viability of E. Coli, S. Aureus, and B. Subtilis bacteria compared with that for the controls. The IC50 values of the venom for E.coli, S.aureus, and B.subtilis were 30.19, 17.64, and 24.13 µM, respectively. Conclusion: The findings suggest that the venom of O. bidentatus scorpion has antibacterial properties. Also, our results offer preliminary clues toward the development of new antibacterial agents and new drugs with high therapeutic potentials for use in animals and humans.
- 1 April 2020
- Published by Apex Publishing in Iranian Journal of Toxicology
- Vol. 14 (2) , 105-110
Antibacterial Activity of the Iranian Scorpion’s Crude Venom (Odontobuthus bidentatus) on Gram-positive and Gram-negative Bacteria
Background: The venoms of some scorpions are rich in bioactive components that may be used in the development and discovery of new antibacterial drugs. The venoms have many components, such as neurotoxins, salts, proteins and peptides with therapeutic properties, and can rapidly eliminate a broad range of bacteria. This study evaluated the anti-bacterial activity of Odontobuthus bidentatus’ crude venom against typical Gram-positive and negative bacteria, such as Staphylococcus aureus, Bacillus subtilis, and Escherichia coli. Methods: The antibacterial effects of the crude venom were evaluated using Minimal Inhibitory Concentration (MIC) and MTT assays and its IC50 value was determined, using GraphPad software. Results: The crude venom significantly inhibited the growth of both Gram-positive and negative bacteria. Also the MTT results showed that the crude venom significantly reduced the viability of E. Coli, S. Aureus, and B. Subtilis bacteria compared with that for the controls. The IC50 values of the venom for E.coli, S.aureus, and B.subtilis were 30.19, 17.64, and 24.13 µM, respectively. Conclusion: The findings suggest that the venom of O. bidentatus scorpion has antibacterial properties. Also, our results offer preliminary clues toward the development of new antibacterial agents and new drugs with high therapeutic potentials for use in animals and humans.